A Clinical Trial Evaluating the Effectiveness and Safety of the PowerMe Midline Catheter in the Chinese Population
- Conditions
- Catheterization
- Interventions
- Device: catheter placement
- First Posted Date
- 2021-01-22
- Last Posted Date
- 2022-09-23
- Lead Sponsor
- Becton, Dickinson and Company
- Target Recruit Count
- 256
- Registration Number
- NCT04719377
- Locations
- 🇨🇳
Hunan Cancer Hospital, Changsha, China
🇨🇳Shanghai First General Hospital, Shanghai, China
🇨🇳The First Affiliated Hospital of Soochow University, Suzhou, China
Clinical Trial for Registration of HPV Nucleic Acid Genotyping Assay Kit
- Conditions
- Cervical Cancer
- Interventions
- Diagnostic Test: HPV Genotyping Nucleic Acid Assay Kit
- First Posted Date
- 2020-07-08
- Last Posted Date
- 2024-03-21
- Lead Sponsor
- Becton, Dickinson and Company
- Target Recruit Count
- 12000
- Registration Number
- NCT04461678
- Locations
- 🇨🇳
Cancer Hospital Chinese Academy of Medical Science, Beijing, Beijing, China
🇨🇳Obstetrics&Gynecology Hospital of Fudan University, Shanghai, Shanghai, China
🇨🇳Henan Cancer Hospital, Zhengzhou, Henan, China
Impact of PIVC Length and Gauge on Catheter Indwell Time
- Conditions
- Indication for Peripheral Intravenous Catheterisation
- Interventions
- Device: Peripheral Intravenous Catheter
- First Posted Date
- 2020-04-14
- Last Posted Date
- 2024-05-16
- Lead Sponsor
- Becton, Dickinson and Company
- Target Recruit Count
- 40
- Registration Number
- NCT04344314
- Locations
- 🇦🇺
Griffith University, Gold Coast, Queensland, Australia
Prospective Observational Study of the Power PICC Family of Devices and Accessories
- Conditions
- Peripherally Inserted Central Catheter
- Interventions
- Device: Peripherally Inserted Central Catheter
- First Posted Date
- 2020-02-11
- Last Posted Date
- 2024-08-19
- Lead Sponsor
- Becton, Dickinson and Company
- Target Recruit Count
- 450
- Registration Number
- NCT04263649
- Locations
- 🇨🇿
Fakultnà nemocnice Olomouc, Olomouc, Czechia
🇮🇹Azienda Ospedaliera Nazionale SS. Antonio e Biagio e Cesare Arrigo, Alessandria, Piedmont, Italy
🇳🇱HAGA Ziekenhuis, Den Haag, Netherlands
The Role of Proper Insulin Injection Technique in the Treatment of Diabetes Mellitus
- Conditions
- LipohypertrophyDiabetes Mellitus, Type 2Diabetes Mellitus, Type 1
- Interventions
- Behavioral: Optimal insulin injection
- First Posted Date
- 2019-10-09
- Last Posted Date
- 2024-02-22
- Lead Sponsor
- Becton, Dickinson and Company
- Target Recruit Count
- 90
- Registration Number
- NCT04120974
- Locations
- 🇷🇺
State Healthcare Institution "Sverdlovsk Regional Clinical Hospital No. 1" (EKB), Ekaterinburg, Russian Federation
🇷🇺National Medical Research Center of Endocrinology (ENC), Moscow, Russian Federation
🇷🇺Moscow Regional Research Clinical Institute (MONIKI), Moscow, Russian Federation
Impact of App Based Diabetes Training Program in Conjunction With the BD Nano Pen Needle in People With T2 Diabetes
- Conditions
- Diabetes Mellitus, Type 2
- Interventions
- Device: BD Diabetes Care Application (for mobile devices) PLUS use of BD Nano Pen Needle
- First Posted Date
- 2019-09-16
- Last Posted Date
- 2021-07-08
- Lead Sponsor
- Becton, Dickinson and Company
- Target Recruit Count
- 58
- Registration Number
- NCT04090242
- Locations
- 🇺🇸
Mills Pennisula Medical Center-Diabetes Research Institute, San Mateo, California, United States
🇺🇸Texas Diabetes and Endocrinology, Austin, Texas, United States
🇺🇸East West Medical Research Institute, Honolulu, Hawaii, United States
Evaluation of the Antimicrobial Effectiveness of CHG/IPA
- Conditions
- Microbial Colonization
- Interventions
- Other: Reference StandardCombination Product: Investigational ProductCombination Product: Active ComparatorOther: Negative Control
- First Posted Date
- 2019-07-29
- Last Posted Date
- 2021-08-17
- Lead Sponsor
- Becton, Dickinson and Company
- Target Recruit Count
- 1935
- Registration Number
- NCT04035161
- Locations
- 🇷🇴
Eurofins Evic Product Testing Romania S.R.L., Bucharest, Romania
An Audit of the Impact of Tailored Information Delivered Via a Digital Learning Platform
- Conditions
- Diabetes Mellitus, Type 1Diabetes Mellitus, Type 2
- Interventions
- Behavioral: training in optimal insulin injection technique
- First Posted Date
- 2019-07-05
- Last Posted Date
- 2019-12-03
- Lead Sponsor
- Becton, Dickinson and Company
- Target Recruit Count
- 170
- Registration Number
- NCT04007003
- Locations
- 🇧🇪
Universitair Ziekenhuis Antwerpen, Antwerpen, Belgium
🇧🇪Imeldaziekenhuis, Bonheiden, Belgium
🇧🇪Universitair Ziekenhuis Brussel, Brussel, Belgium
Comparative User Experiences With BD Nano™ PRO 32G Extra Thin Wall Pen Needle vs the Terumo Nanopass® 34G Pen Needle
- Conditions
- Diabetes
- Interventions
- Device: Terumo Nanopass® 34G pen needleDevice: BD Nano™ PRO 32G pen needle
- First Posted Date
- 2019-03-18
- Last Posted Date
- 2020-05-19
- Lead Sponsor
- Becton, Dickinson and Company
- Target Recruit Count
- 55
- Registration Number
- NCT03878745
- Locations
- 🇺🇸
Mills-Peninsula Medical Center Dorothy L. and James E Frank Diabetes Research Institute, San Mateo, California, United States
🇺🇸East West Medical Research Institute, Honolulu, Hawaii, United States
Comparative User Experiences With BD Nanoâ„¢ PRO 4mm x 32G Extra Thin Wall Pen Needle vs Three Commercially Available Pen Needles
- Conditions
- Diabetes
- Interventions
- Device: BD Nanoâ„¢ PRODevice: 34G Artsana Insupen Extr3meDevice: 33G Artsana Insupen Extr3meDevice: Simple Diagnostics Comfort EZâ„¢
- First Posted Date
- 2019-03-18
- Last Posted Date
- 2020-03-09
- Lead Sponsor
- Becton, Dickinson and Company
- Target Recruit Count
- 158
- Registration Number
- NCT03878758
- Locations
- 🇺🇸
East West Medical Research Institute, Honolulu, Hawaii, United States
🇺🇸TKL Research Inc., Fair Lawn, New Jersey, United States